Hims & Hers Health, a leading health and wellness platform, has announced the appointment of Kåre Schultz to its Board of Directors. Schultz, known for his extensive global expertise in…
Lario Therapeutics Secures $6M Grant from Michael J. Fox Foundation for Parkinson’s Research Lario Therapeutics, a biopharmaceutical company focused on pioneering precision medicines for neurological and epileptic disorders, has announced…
Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation (EJAF) have announced a five-year extension of the RADIAN® partnership to address the growing HIV crisis in Eastern Europe…
AIDS Healthcare Foundation (AHF) will hold an in-person and virtual press conference at the AHF booth (#111) during the 2024 International AIDS Conference (AIDS 2024) on Tuesday, July 23, at…
Rusan Pharma, an India-based pharmaceutical company specializing in addiction treatment and pain management, recently announced that the United States Food and Drug Administration (USFDA) has granted Good Manufacturing Practice (GMP)…
Ionis Pharmaceuticals today revealed that it has finalized enrollment in its pivotal trial evaluating zilganersen (ION373), an investigational RNA-targeted therapy aimed at treating children and adults with Alexander disease (AxD),…
WHO and UNICEF have unveiled new national immunization coverage estimates (WUENIC), offering the most comprehensive view of global vaccination trends for 13 diseases. The findings present both progress and pressing…
The WHO is actively participating in the 25th International AIDS Conference (AIDS 2024) in Munich, Germany, and online from July 20 to 26. During a series of pre-conference sessions and…
Each year, over a million people acquire preventable HIV infections, and many others with HIV remain undiagnosed and untreated. Quality testing services are crucial for reaching, treating, and preventing HIV,…
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino) announced today that its Korean subsidiary, Ono Pharma Korea Co., Ltd. (OPKR), received additional approval from South Korea’s Ministry of…
Neurocrine Biosciences has introduced a new sprinkle formulation of INGREZZA® (valbenazine) capsules, the leading VMAT2 inhibitor for treating adults with tardive dyskinesia and chorea associated with Huntington’s disease. This new…
Labcorp, a leading global life sciences company, has been recognized as a top employer for disability inclusion by achieving a perfect score of 100 on the 2024 Disability Equality Index®.…